Clinical Trial Update: Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD [Phase 4]

View source ↗

Summary

Phase 4 study evaluating berberine for reducing abdominal visceral adipose tissue in individuals with obesity and NAFLD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Obesity, Obesity, Abdominal | Phase 4 | Status: COMPLETED